A high density of CD3+/CD8+ tumour-infiltrating lymphocytes (termed Immunoscore) and positive staining for PD-L1 expression indicate pre-existing anti-tumour immune activity and can be used as biomarkers to predict response. This evidence concerns the gene CD8A and neoplasm.